Whitehawk Therapeutics to Participate in Upcoming Investor Conferences
Whitehawk’s CFO and CSO fireside chat at Morgan Stanley will be webcast live Sept. 9–10 and replayed for about 30 days on the IR site.
Rhea-AI Summary
Whitehawk Therapeutics (WHWK)/b) will participate in three September 2026 healthcare investor conferences, including a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026, at 1:05 PM ET.Management will hold investor meetings at the Cantor Global Healthcare Conference on September 9 and the Wells Fargo 21st Annual Healthcare Conference on September 10. The Morgan Stanley fireside chat with the CFO and CSO will be webcast live on the company’s IR website and remain available for replay for about 30 days.
Positive
- None.
Negative
- None.
News Market Reaction – WHWK
In the Sep 2 session, WHWK gained 1.73%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- Cantor Global Healthcare Conference 2026 – management will participate in investor meetings on September 9, 2026.
- Wells Fargo 21st Annual Healthcare Conference – management will participate in investor meetings on September 10, 2026.
- Morgan Stanley 24th Annual Global Healthcare Conference – management will participate in investor meetings, and Scott Giacobello, Chief Financial Officer, and David Dornan, PhD, Chief Scientific Officer, will participate in a fireside chat on September 15, 2026, at 1:05 PM ET.
A live webcast of the fireside chat can be accessed by visiting the Whitehawk Therapeutics IR website and will be available for replay for approximately 30 days following the event.
About Whitehawk Therapeutics
Whitehawk Therapeutics is a clinical-stage oncology therapeutics company applying advanced technologies to established tumor biology to efficiently develop improved cancer treatments. Whitehawk's portfolio includes HWK-007, HWK-016 and HWK-206, ADCs engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers. These assets are in-licensed from WuXi Biologics under an exclusive development and global commercialization agreement.
Whitehawk's underlying ADC platform leverages CPT113 as the core linker-payload technology, enhanced with its proprietary Carbon Bridge Cysteine Re-pairing (CBCR) bioconjugation process to support improved stability and therapeutic index. Whitehawk has an option agreement with Hangzhou DAC for access to CPT113 for use in up to five additional ADC programs. More information on the Company is available at www.whitehawktx.com and connect with us on LinkedIn. Any references to the Company's website or other online resources are provided solely for convenience and are not incorporated by reference into this press release. Investors should rely only on the information contained in this press release and the Company's filings with the Securities and Exchange Commission
Contact:
IR@whitehawktx.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/whitehawk-therapeutics-to-participate-in-upcoming-investor-conferences-302866078.html
SOURCE Whitehawk Therapeutics, Inc.
FAQ
Which investor conferences will Whitehawk Therapeutics (WHWK) attend in September 2026?
Whitehawk Therapeutics will attend three conferences in September 2026: the Cantor Global Healthcare Conference on September 9, the Wells Fargo 21st Annual Healthcare Conference on September 10, and the Morgan Stanley 24th Annual Global Healthcare Conference on September 15.
When is the Whitehawk Therapeutics (WHWK) fireside chat at the Morgan Stanley Global Healthcare Conference?
The Whitehawk Therapeutics fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference is scheduled for September 15, 2026, at 1:05 PM ET.
Who from Whitehawk Therapeutics (WHWK) will speak at the Morgan Stanley fireside chat?
At the Morgan Stanley 24th Annual Global Healthcare Conference, Chief Financial Officer Scott Giacobello and Chief Scientific Officer David Dornan, PhD, will participate in the fireside chat on September 15, 2026.
How can investors access the Whitehawk Therapeutics (WHWK) Morgan Stanley fireside chat webcast?
The live webcast of Whitehawk Therapeutics’ fireside chat can be accessed via the company’s investor relations (IR) website and will be available as a replay for approximately 30 days following the event.
Will there be investor meetings for Whitehawk Therapeutics (WHWK) at the Cantor and Wells Fargo conferences?
Yes. Whitehawk Therapeutics management will participate in investor meetings at the Cantor Global Healthcare Conference on September 9, 2026, and at the Wells Fargo 21st Annual Healthcare Conference on September 10, 2026.